+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Custom Synthetic Genes Services Market by Technology, Product, End User, Application, Gene Type - Global Forecast to 2030- Product Image
Custom Synthetic Genes Services Market by Technology, Product, End User, Application, Gene Type - Global Forecast to 2030- Product Image
Sale

Custom Synthetic Genes Services Market by Technology, Product, End User, Application, Gene Type - Global Forecast to 2030

  • PDF Icon

    Report

  • 182 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6085215
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Unveiling the Evolution of Custom Synthetic Genes

Custom synthetic gene services have become foundational to modern biotechnology and life sciences research, powering innovations across therapeutics, diagnostics, and basic research. By enabling the precise design and assembly of genetic sequences, these services accelerate discovery timelines, reduce R&D costs, and support applications ranging from gene therapy to agricultural bioengineering. Over the past decade, advances in high-throughput synthesis platforms and improvements in error correction methodologies have dramatically increased the fidelity and throughput of gene synthesis. As a result, organizations that once relied on manual cloning approaches are now harnessing automated pipelines capable of generating thousands of constructs per week.

This shift has not only democratized access to custom constructs but also driven down per-base-pair costs, making bespoke gene design a viable option for academic and commercial entities alike. Emerging techniques in synthetic biology, such as modular DNA assembly and automation-enabled library construction, have further expanded the scope of what can be achieved through outsourced gene synthesis. In response, service providers have diversified their offerings to include end-to-end solutions encompassing design consultation, scaled production, and post-synthesis validation. Consequently, decision-makers must now navigate a landscape defined by rapid technological iteration, stringent quality expectations, and evolving regulatory frameworks. Understanding these foundational trends is critical to assessing the strategic value of custom synthetic gene services within your organization, whether your focus lies in novel therapeutic constructs or high-throughput functional screens.

Pioneering Shifts Redefining the Synthetic Gene Market

The synthetic gene market is undergoing transformative shifts as new methodologies redefine productivity and cost structures. A key driver of change lies in the convergence of DNA synthesis, gene construction, and gene editing technologies into cohesive service portfolios. Providers are integrating de novo gene synthesis and oligonucleotide services with advanced cloning techniques, such as recombinant and restriction-based methods, to furnish seamless end-to-end workflows. At the same time, gene editing platforms like CRISPR Cas9, TALEN, and Zinc Finger are being offered alongside custom guide RNA and mRNA production, enabling clients to pursue complex functional genomics experiments without the overhead of in-house development.

Another pivotal trend is the increasing adoption of multiplexed synthesis and high-throughput screening assays, which allow researchers to evaluate hundreds or thousands of variants in parallel. This development is particularly impactful in therapeutic discovery, where rapid prototyping of gene constructs can accelerate lead identification for gene therapies and biologics. Simultaneously, the integration of machine learning algorithms for sequence optimization is enhancing error prediction and synthesis success rates. Collectively, these innovations are shifting the competitive parameters from basic delivery capacity and turnaround time toward comprehensive solution quality, customization depth, and data-driven design support.

Unraveling the Impact of U.S. Tariff Adjustments in 2025

In 2025, the imposition of revised United States tariffs on imported gene synthesis reagents and consumables introduced a new complexity to the cost structure facing service providers and end users. These tariffs, which affect key substrates and enzyme kits, have increased procurement expenses for both domestic and international laboratories. Service providers have responded by reevaluating supply chains, expanding local manufacturing partnerships, and in some cases, passing through incremental costs to clients. The result has been a recalibration of pricing strategies, with some providers offering bundled design and synthesis packages to mitigate the impact of higher reagent costs.

Despite the immediate cost pressures, the market has shown resilience as many organizations prioritize reliability and quality over marginal price increases. Moreover, the tariffs have spurred a wave of localized innovation, with reagent suppliers and service providers investing in alternative chemistries and process optimizations to maintain competitive pricing. As a consequence, end users are gaining access to new reagent formulations and proprietary synthesis techniques that may offer performance advantages beyond cost savings. In the medium term, the tariff-induced shift is likely to accelerate the geographic diversification of the supply base, reduce single-source dependencies, and strengthen domestic capabilities within the gene synthesis ecosystem.

Decoding Market Dynamics Through Strategic Segmentation

Analyzing the market through a multi-faceted segmentation lens yields critical insights into growth drivers and competitive dynamics. When grouped by technology, the landscape reveals a strong appetite for DNA synthesis methods, particularly de novo gene synthesis and oligonucleotide services, while gene construction via recombinant cloning and restriction cloning remains essential for bespoke assembly needs. Gene editing services centered on CRISPR Cas9 dominate the R&D pipeline, yet TALEN and Zinc Finger techniques retain niche applications in therapeutic development and regulatory-sensitive projects.

Shifting to a product-based perspective highlights distinct demand patterns for CRISPR guide RNA, Gblocks, mRNA constructs, oligonucleotide synthesis, and plasmid DNA. Within this array, guide RNA and mRNA services capture significant share due to their critical role in cell therapy and vaccine development. The end-user segmentation underscores strong uptake in academic institutions and biotech companies, with contract research organizations and pharmaceutical companies driving large-scale projects. Application-based analysis differentiates demand across agriculture, diagnostics, research, and therapeutics, illustrating how each vertical leverages custom gene services to solve unique challenges. Finally, examining gene types-guide RNA, mRNA, plasmid vectors, and viral vectors-reveals that viral vectors are gaining momentum in gene therapy pipelines, even as non-viral constructs continue to dominate high-throughput screening workflows.

Regional Variations Shaping Global Gene Synthesis Demand

Regional trends in the custom synthetic gene market reflect varied growth trajectories influenced by research investment, regulatory environments, and infrastructure maturity. In the Americas, robust funding for biotechnology R&D and established clinical trial ecosystems underpin strong demand for end-to-end gene synthesis and editing services. North American providers are expanding capacity to cater to burgeoning gene therapy pipelines and precision medicine initiatives. Europe, Middle East & Africa present a diversified picture, with Western European nations driving early adoption through government-supported genomic programs, while emerging markets are gradually increasing investment in agricultural biotechnology and diagnostic capabilities. Regulatory harmonization efforts are facilitating cross-border collaborations, enabling service providers to navigate complex approval pathways more efficiently.

In Asia-Pacific, rapid industrialization, government incentives for biotech startups, and large-scale genomics projects in countries like China, Japan, and India are creating a fertile environment for service expansion. Local providers are increasingly establishing global partnerships to meet quality standards and accelerate entry into new markets. Across all regions, the interplay between academic research funding, commercial R&D budgets, and public health priorities continues to shape procurement strategies and service offerings.

Competitive Landscape and Leading Industry Players

The competitive landscape of custom synthetic genes is populated by leading life science conglomerates, specialized synthesis firms, and nimble startups. Major players have leveraged global manufacturing footprints, integrated service portfolios, and robust quality certifications to maintain market leadership. These companies invest heavily in automated synthesis platforms, proprietary error correction technologies, and scalable production capacity. Meanwhile, emerging firms differentiate through innovative service models, such as rapid-turnaround microarray synthesis, custom library creation, and AI-driven design tools.

Partnerships and strategic acquisitions have become common tactics for expanding technological capabilities and geographic reach. While established providers benefit from brand recognition and longstanding customer relationships, smaller companies are capitalizing on niche specialization and flexibility to serve high-value projects. Both tiers of competitors prioritize investments in customer support, digital ordering platforms, and post-delivery validation services to meet increasingly stringent user expectations. This dynamic environment rewards firms that can seamlessly integrate design expertise with manufacturing excellence, ensuring clients receive reliable, end-to-end solutions.

Strategic Imperatives for Industry Leadership Success

To succeed in the evolving custom synthetic gene market, industry leaders must align their strategies with the technological, regulatory, and commercial realities of 2025 and beyond. First, enhancing supply chain resilience through diversified sourcing of critical reagents and strategic manufacturing partnerships will mitigate tariff-related cost pressures and global disruptions. Second, investing in automation and machine learning for sequence design and error correction will not only improve throughput but also differentiate service quality. Third, expanding value-added offerings-such as design consultation, data analytics, and downstream validation-will strengthen client relationships and create new revenue streams.

Leaders should also prioritize geographic expansion into high-growth regions, tailoring service models to local regulatory frameworks and research priorities. Engaging in collaborative alliances with academic institutions, contract research organizations, and biotech incubators can amplify market presence and foster co-development opportunities. Finally, transparent pricing structures, flexible turnaround options, and robust quality management systems will be essential to build trust and maintain competitive advantage in a market where precision and reliability are paramount.

Robust Methodological Approach Ensuring Research Integrity

This analysis is grounded in a rigorous research methodology combining primary and secondary sources to ensure accuracy and comprehensiveness. Primary research encompassed in-depth interviews with industry executives, R&D leaders, and procurement officers across technology providers, end users, and regulatory bodies. These interviews provided real-world perspectives on operational challenges, pricing dynamics, and future investment priorities.

Secondary research drew on peer-reviewed journals, patent filings, regulatory agency publications, technical white papers, and company disclosures to validate market trends and technology trajectories. Data on trade flows, tariff schedules, and regional funding allocations were integrated to assess the impact of the 2025 U.S. tariff adjustments. Market segmentation was constructed using a combination of product shipment data, service revenue reports, and end-user deployment statistics. Cross-verification and triangulation techniques were applied to resolve discrepancies and ensure data integrity. The result is a robust, unbiased synthesis of the custom synthetic gene services landscape.

Synthesizing Insights to Drive Informed Decision Making

In synthesizing these insights, it becomes clear that custom synthetic gene services are entering a phase defined by integrated solutions, data-driven design, and geographically diversified growth. The 2025 tariff changes, while disruptive, have catalyzed supply chain innovation and stimulated localized reagent development. Segmentation analysis highlights the expanding role of gene editing and vector design in therapeutic pipelines, as well as sustained demand from academic and biotech ecosystems.

Regional dynamics underscore the significance of strategic market entry, with the Americas, Europe, Middle East & Africa, and Asia-Pacific each presenting unique regulatory and investment landscapes. The competitive environment rewards those who can deliver high-fidelity, customizable services at scale while nurturing collaborative partnerships. For decision-makers, the imperative is to leverage advanced automation, resilient sourcing strategies, and value-added offerings to capitalize on emerging opportunities. By aligning capabilities with evolving customer needs and regulatory trends, industry participants can position themselves for sustainable growth and innovation.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Technology
    • DNA Synthesis
      • De Novo Gene Synthesis
      • Oligonucleotide Services
    • Gene Construction
      • Recombinant Cloning
      • Restriction Cloning
    • Gene Editing
      • CRISPR Cas9
      • TALEN
      • Zinc Finger
  • Product
    • CRISPR Guide RNA
    • Gblocks
    • mRNA
    • Oligonucleotide Synthesis
    • Plasmid DNA
  • End User
    • Academic Institutions
    • Biotech Companies
    • Contract Research Organizations
    • Pharmaceutical Companies
  • Application
    • Agriculture
    • Diagnostics
    • Research
    • Therapeutics
  • Gene Type
    • Guide RNA
    • mRNA
    • Plasmid Vectors
    • Viral Vectors
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Integrated DNA Technologies, Inc.
  • GenScript Biotech Corporation
  • Twist Bioscience Corporation
  • Agilent Technologies, Inc.
  • Eurofins Scientific SE
  • ATUM, Inc.
  • Bio Basic, Inc.
  • BGI Genomics Co., Ltd.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Custom Synthetic Genes Services Market, by Technology
8.1. Introduction
8.2. DNA Synthesis
8.2.1. De Novo Gene Synthesis
8.2.2. Oligonucleotide Services
8.3. Gene Construction
8.3.1. Recombinant Cloning
8.3.2. Restriction Cloning
8.4. Gene Editing
8.4.1. CRISPR Cas9
8.4.2. TALEN
8.4.3. Zinc Finger
9. Custom Synthetic Genes Services Market, by Product
9.1. Introduction
9.2. CRISPR Guide RNA
9.3. Gblocks
9.4. mRNA
9.5. Oligonucleotide Synthesis
9.6. Plasmid DNA
10. Custom Synthetic Genes Services Market, by End User
10.1. Introduction
10.2. Academic Institutions
10.3. Biotech Companies
10.4. Contract Research Organizations
10.5. Pharmaceutical Companies
11. Custom Synthetic Genes Services Market, by Application
11.1. Introduction
11.2. Agriculture
11.3. Diagnostics
11.4. Research
11.5. Therapeutics
12. Custom Synthetic Genes Services Market, by Gene Type
12.1. Introduction
12.2. Guide RNA
12.3. mRNA
12.4. Plasmid Vectors
12.5. Viral Vectors
13. Americas Custom Synthetic Genes Services Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Custom Synthetic Genes Services Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Custom Synthetic Genes Services Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Thermo Fisher Scientific Inc.
16.3.2. Merck KGaA
16.3.3. Integrated DNA Technologies, Inc.
16.3.4. GenScript Biotech Corporation
16.3.5. Twist Bioscience Corporation
16.3.6. Agilent Technologies, Inc.
16.3.7. Eurofins Scientific SE
16.3.8. ATUM, Inc.
16.3.9. Bio Basic, Inc.
16.3.10. BGI Genomics Co., Ltd.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. CUSTOM SYNTHETIC GENES SERVICES MARKET MULTI-CURRENCY
FIGURE 2. CUSTOM SYNTHETIC GENES SERVICES MARKET MULTI-LANGUAGE
FIGURE 3. CUSTOM SYNTHETIC GENES SERVICES MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE TYPE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. CUSTOM SYNTHETIC GENES SERVICES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. CUSTOM SYNTHETIC GENES SERVICES MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. CUSTOM SYNTHETIC GENES SERVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY DNA SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY DE NOVO GENE SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY OLIGONUCLEOTIDE SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY DNA SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE CONSTRUCTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY RECOMBINANT CLONING, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY RESTRICTION CLONING, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE CONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE EDITING, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY CRISPR CAS9, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY TALEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY ZINC FINGER, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE EDITING, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY CRISPR GUIDE RNA, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GBLOCKS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY MRNA, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY OLIGONUCLEOTIDE SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PLASMID DNA, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY BIOTECH COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY AGRICULTURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GUIDE RNA, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY MRNA, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PLASMID VECTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY VIRAL VECTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY DNA SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE CONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE EDITING, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY DNA SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE CONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE EDITING, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 59. CANADA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 60. CANADA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY DNA SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 61. CANADA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE CONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 62. CANADA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE EDITING, 2018-2030 (USD MILLION)
TABLE 63. CANADA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 64. CANADA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 65. CANADA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 66. CANADA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 67. MEXICO CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 68. MEXICO CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY DNA SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 69. MEXICO CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE CONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 70. MEXICO CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE EDITING, 2018-2030 (USD MILLION)
TABLE 71. MEXICO CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 72. MEXICO CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 73. MEXICO CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 74. MEXICO CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 75. BRAZIL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 76. BRAZIL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY DNA SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 77. BRAZIL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE CONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 78. BRAZIL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE EDITING, 2018-2030 (USD MILLION)
TABLE 79. BRAZIL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 80. BRAZIL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 81. BRAZIL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 82. BRAZIL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 83. ARGENTINA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 84. ARGENTINA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY DNA SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 85. ARGENTINA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE CONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 86. ARGENTINA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE EDITING, 2018-2030 (USD MILLION)
TABLE 87. ARGENTINA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 88. ARGENTINA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 89. ARGENTINA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 90. ARGENTINA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 91. EUROPE, MIDDLE EAST & AFRICA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 92. EUROPE, MIDDLE EAST & AFRICA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY DNA SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 93. EUROPE, MIDDLE EAST & AFRICA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE CONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 94. EUROPE, MIDDLE EAST & AFRICA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE EDITING, 2018-2030 (USD MILLION)
TABLE 95. EUROPE, MIDDLE EAST & AFRICA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 96. EUROPE, MIDDLE EAST & AFRICA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 97. EUROPE, MIDDLE EAST & AFRICA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 98. EUROPE, MIDDLE EAST & AFRICA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 100. UNITED KINGDOM CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 101. UNITED KINGDOM CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY DNA SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 102. UNITED KINGDOM CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE CONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 103. UNITED KINGDOM CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE EDITING, 2018-2030 (USD MILLION)
TABLE 104. UNITED KINGDOM CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 105. UNITED KINGDOM CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 106. UNITED KINGDOM CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 107. UNITED KINGDOM CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 108. GERMANY CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 109. GERMANY CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY DNA SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 110. GERMANY CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE CONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 111. GERMANY CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE EDITING, 2018-2030 (USD MILLION)
TABLE 112. GERMANY CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 113. GERMANY CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 114. GERMANY CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 115. GERMANY CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 116. FRANCE CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 117. FRANCE CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY DNA SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 118. FRANCE CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE CONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 119. FRANCE CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE EDITING, 2018-2030 (USD MILLION)
TABLE 120. FRANCE CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 121. FRANCE CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 122. FRANCE CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 123. FRANCE CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 124. RUSSIA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 125. RUSSIA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY DNA SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 126. RUSSIA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE CONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 127. RUSSIA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE EDITING, 2018-2030 (USD MILLION)
TABLE 128. RUSSIA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 129. RUSSIA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 130. RUSSIA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 131. RUSSIA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 132. ITALY CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 133. ITALY CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY DNA SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 134. ITALY CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE CONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 135. ITALY CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE EDITING, 2018-2030 (USD MILLION)
TABLE 136. ITALY CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 137. ITALY CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 138. ITALY CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 139. ITALY CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 140. SPAIN CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 141. SPAIN CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY DNA SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 142. SPAIN CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE CONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 143. SPAIN CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE EDITING, 2018-2030 (USD MILLION)
TABLE 144. SPAIN CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 145. SPAIN CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 146. SPAIN CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 147. SPAIN CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 148. UNITED ARAB EMIRATES CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 149. UNITED ARAB EMIRATES CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY DNA SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 150. UNITED ARAB EMIRATES CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE CONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 151. UNITED ARAB EMIRATES CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE EDITING, 2018-2030 (USD MILLION)
TABLE 152. UNITED ARAB EMIRATES CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 153. UNITED ARAB EMIRATES CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 154. UNITED ARAB EMIRATES CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 155. UNITED ARAB EMIRATES CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 156. SAUDI ARABIA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 157. SAUDI ARABIA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY DNA SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 158. SAUDI ARABIA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE CONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 159. SAUDI ARABIA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE EDITING, 2018-2030 (USD MILLION)
TABLE 160. SAUDI ARABIA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 161. SAUDI ARABIA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 162. SAUDI ARABIA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 163. SAUDI ARABIA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 164. SOUTH AFRICA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 165. SOUTH AFRICA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY DNA SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 166. SOUTH AFRICA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE CONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 167. SOUTH AFRICA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE EDITING, 2018-2030 (USD MILLION)
TABLE 168. SOUTH AFRICA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 169. SOUTH AFRICA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 170. SOUTH AFRICA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 171. SOUTH AFRICA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 172. DENMARK CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 173. DENMARK CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY DNA SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 174. DENMARK CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE CONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 175. DENMARK CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE EDITING, 2018-2030 (USD MILLION)
TABLE 176. DENMARK CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 177. DENMARK CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 178. DENMARK CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 179. DENMARK CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 180. NETHERLANDS CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 181. NETHERLANDS CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY DNA SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 182. NETHERLANDS CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE CONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 183. NETHERLANDS CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE EDITING, 2018-2030 (USD MILLION)
TABLE 184. NETHERLANDS CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 185. NETHERLANDS CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 186. NETHERLANDS CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 187. NETHERLANDS CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 188. QATAR CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 189. QATAR CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY DNA SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 190. QATAR CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE CONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 191. QATAR CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE EDITING, 2018-2030 (USD MILLION)
TABLE 192. QATAR CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 193. QATAR CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 194. QATAR CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 195. QATAR CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 196. FINLAND CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 197. FINLAND CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY DNA SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 198. FINLAND CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE CONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 199. FINLAND CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE EDITING, 2018-2030 (USD MILLION)
TABLE 200. FINLAND CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 201. FINLAND CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 202. FINLAND CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 203. FINLAND CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 204. SWEDEN CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 205. SWEDEN CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY DNA SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 206. SWEDEN CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE CONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 207. SWEDEN CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE EDITING, 2018-2030 (USD MILLION)
TABLE 208. SWEDEN CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 209. SWEDEN CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 210. SWEDEN CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 211. SWEDEN CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 212. NIGERIA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 213. NIGERIA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY DNA SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 214. NIGERIA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE CONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 215. NIGERIA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE EDITING, 2018-2030 (USD MILLION)
TABLE 216. NIGERIA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 217. NIGERIA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 218. NIGERIA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 219. NIGERIA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 220. EGYPT CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 221. EGYPT CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY DNA SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 222. EGYPT CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE CONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 223. EGYPT CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE EDITING, 2018-2030 (USD MILLION)
TABLE 224. EGYPT CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 225. EGYPT CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 226. EGYPT CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 227. EGYPT CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 228. TURKEY CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 229. TURKEY CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY DNA SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 230. TURKEY CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE CONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 231. TURKEY CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE EDITING, 2018-2030 (USD MILLION)
TABLE 232. TURKEY CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 233. TURKEY CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 234. TURKEY CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 235. TURKEY CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 236. ISRAEL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 237. ISRAEL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY DNA SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 238. ISRAEL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE CONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 239. ISRAEL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE EDITING, 2018-2030 (USD MILLION)
TABLE 240. ISRAEL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 241. ISRAEL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 242. ISRAEL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 243. ISRAEL CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 244. NORWAY CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 245. NORWAY CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY DNA SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 246. NORWAY CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE CONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 247. NORWAY CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE EDITING, 2018-2030 (USD MILLION)
TABLE 248. NORWAY CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 249. NORWAY CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 250. NORWAY CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 251. NORWAY CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 252. POLAND CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 253. POLAND CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY DNA SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 254. POLAND CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE CONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 255. POLAND CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE EDITING, 2018-2030 (USD MILLION)
TABLE 256. POLAND CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 257. POLAND CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 258. POLAND CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 259. POLAND CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 260. SWITZERLAND CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 261. SWITZERLAND CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY DNA SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 262. SWITZERLAND CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE CONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 263. SWITZERLAND CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE EDITING, 2018-2030 (USD MILLION)
TABLE 264. SWITZERLAND CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 265. SWITZERLAND CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 266. SWITZERLAND CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 267. SWITZERLAND CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 268. ASIA-PACIFIC CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 269. ASIA-PACIFIC CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY DNA SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 270. ASIA-PACIFIC CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE CONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 271. ASIA-PACIFIC CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE EDITING, 2018-2030 (USD MILLION)
TABLE 272. ASIA-PACIFIC CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 273. ASIA-PACIFIC CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 274. ASIA-PACIFIC CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 275. ASIA-PACIFIC CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 276. ASIA-PACIFIC CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 277. CHINA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 278. CHINA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY DNA SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 279. CHINA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE CONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 280. CHINA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE EDITING, 2018-2030 (USD MILLION)
TABLE 281. CHINA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 282. CHINA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 283. CHINA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 284. CHINA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 285. INDIA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 286. INDIA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY DNA SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 287. INDIA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE CONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 288. INDIA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE EDITING, 2018-2030 (USD MILLION)
TABLE 289. INDIA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 290. INDIA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 291. INDIA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 292. INDIA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 293. JAPAN CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 294. JAPAN CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY DNA SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 295. JAPAN CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE CONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 296. JAPAN CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE EDITING, 2018-2030 (USD MILLION)
TABLE 297. JAPAN CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 298. JAPAN CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 299. JAPAN CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 300. JAPAN CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 301. AUSTRALIA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 302. AUSTRALIA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY DNA SYNTHESIS, 2018-2030 (USD MILLION)
TABLE 303. AUSTRALIA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE CONSTRUCTION, 2018-2030 (USD MILLION)
TABLE 304. AUSTRALIA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE EDITING, 2018-2030 (USD MILLION)
TABLE 305. AUSTRALIA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 306. AUSTRALIA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 307. AUSTRALIA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 308. AUSTRALIA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
TABLE 309. SOUTH KOREA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 310. SOUTH KOREA CUSTOM SYNTHETIC GENES SERVICES MARKET SIZE, BY DNA SYNTHESIS, 2018-20

Companies Mentioned

The companies profiled in this Custom Synthetic Genes Services market report include:
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Integrated DNA Technologies, Inc.
  • GenScript Biotech Corporation
  • Twist Bioscience Corporation
  • Agilent Technologies, Inc.
  • Eurofins Scientific SE
  • ATUM, Inc.
  • Bio Basic, Inc.
  • BGI Genomics Co., Ltd.

Methodology

Loading
LOADING...

Related Topics

Related Reports

Synthetic Genes - Global Strategic Business Report - Product Image

Synthetic Genes - Global Strategic Business Report

  • Report
  • 89 Pages
  • Global
From
Custom Plasmid Production & Manufacturing Market by Service Type, Application, End User, Plasmid Type, Scale - Global Forecast to 2030 - Product Image

Custom Plasmid Production & Manufacturing Market by Service Type, Application, End User, Plasmid Type, Scale - Global Forecast to 2030

  • Report
  • 183 Pages
  • Global
From
DNA and Gene Cloning Services - Global Strategic Business Report - Product Image

DNA and Gene Cloning Services - Global Strategic Business Report

  • Report
  • 178 Pages
  • Global
From
DNA And Gene Cloning Services Market Size, Share & Trends Analysis Report By Service (Gene Synthesis, Custom Cloning), By Application (DNA Sequencing, Mutagenesis), By End Use, By Region, And Segment Forecasts, 2024 - 2030 - Product Image

DNA And Gene Cloning Services Market Size, Share & Trends Analysis Report By Service (Gene Synthesis, Custom Cloning), By Application (DNA Sequencing, Mutagenesis), By End Use, By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 120 Pages
  • Global
From
DNA Fragments Market by Type, Product Type, Application, End-User - Global Forecast to 2030 - Product Image

DNA Fragments Market by Type, Product Type, Application, End-User - Global Forecast to 2030

  • Report
  • 184 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.